skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys

Epidemiology and psychiatric sciences, 2015-06, Vol.24 (3), p.210-226 [Peer Reviewed Journal]

Copyright © Cambridge University Press 2015 ;Distributed under a Creative Commons Attribution 4.0 International License ;Cambridge University Press 2015 2015 Cambridge University Press ;ISSN: 2045-7960 ;EISSN: 2045-7979 ;DOI: 10.1017/S2045796015000189 ;PMID: 25720357

Full text available

Citations Cited by
  • Title:
    Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
  • Author: Kessler, R. C. ; Sampson, N. A. ; Berglund, P. ; Gruber, M. J. ; Al-Hamzawi, A. ; Andrade, L. ; Bunting, B. ; Demyttenaere, K. ; Florescu, S. ; de Girolamo, G. ; Gureje, O. ; He, Y. ; Hu, C. ; Huang, Y. ; Karam, E. ; Kovess-Masfety, V. ; Lee, S ; Levinson, D. ; Medina Mora, M. E. ; Moskalewicz, J. ; Nakamura, Y. ; Navarro-Mateu, F. ; Browne, M. A. Oakley ; Piazza, M. ; Posada-Villa, J. ; Slade, T. ; ten Have, M. ; Torres, Y. ; Vilagut, G. ; Xavier, M. ; Zarkov, Z. ; Shahly, V. ; Wilcox, M. A.
  • Subjects: Anxieties ; Comorbidity ; Epidemiology ; Life Sciences ; Mental depression ; Santé publique et épidémiologie ; Special ; Special Articles
  • Is Part Of: Epidemiology and psychiatric sciences, 2015-06, Vol.24 (3), p.210-226
  • Description: To examine cross-national patterns and correlates of lifetime and 12-month comorbid DSM-IV anxiety disorders among people with lifetime and 12-month DSM-IV major depressive disorder (MDD). Nationally or regionally representative epidemiological interviews were administered to 74 045 adults in 27 surveys across 24 countries in the WHO World Mental Health (WMH) Surveys. DSM-IV MDD, a wide range of comorbid DSM-IV anxiety disorders, and a number of correlates were assessed with the WHO Composite International Diagnostic Interview (CIDI). 45.7% of respondents with lifetime MDD (32.0-46.5% inter-quartile range (IQR) across surveys) had one of more lifetime anxiety disorders. A slightly higher proportion of respondents with 12-month MDD had lifetime anxiety disorders (51.7%, 37.8-54.0% IQR) and only slightly lower proportions of respondents with 12-month MDD had 12-month anxiety disorders (41.6%, 29.9-47.2% IQR). Two-thirds (68%) of respondents with lifetime comorbid anxiety disorders and MDD reported an earlier age-of-onset (AOO) of their first anxiety disorder than their MDD, while 13.5% reported an earlier AOO of MDD and the remaining 18.5% reported the same AOO of both disorders. Women and previously married people had consistently elevated rates of lifetime and 12-month MDD as well as comorbid anxiety disorders. Consistently higher proportions of respondents with 12-month anxious than non-anxious MDD reported severe role impairment (64.4 v. 46.0%; χ 2 1 = 187.0, p < 0.001) and suicide ideation (19.5 v. 8.9%; χ 2 1 = 71.6, p < 0.001). Significantly more respondents with 12-month anxious than non-anxious MDD received treatment for their depression in the 12 months before interview, but this difference was more pronounced in high-income countries (68.8 v. 45.4%; χ 2 1 = 108.8, p < 0.001) than low/middle-income countries (30.3 v. 20.6%; χ 2 1 = 11.7, p < 0.001). Patterns and correlates of comorbid DSM-IV anxiety disorders among people with DSM-IV MDD are similar across WMH countries. The narrow IQR of the proportion of respondents with temporally prior AOO of anxiety disorders than comorbid MDD (69.6-74.7%) is especially noteworthy. However, the fact that these proportions are not higher among respondents with 12-month than lifetime comorbidity means that temporal priority between lifetime anxiety disorders and MDD is not related to MDD persistence among people with anxious MDD. This, in turn, raises complex questions about the relative importance of temporally primary anxiety disorders as risk markers v. causal risk factors for subsequent MDD onset and persistence, including the possibility that anxiety disorders might primarily be risk markers for MDD onset and causal risk factors for MDD persistence.
  • Publisher: Cambridge, UK: Cambridge University Press
  • Language: English;Italian
  • Identifier: ISSN: 2045-7960
    EISSN: 2045-7979
    DOI: 10.1017/S2045796015000189
    PMID: 25720357
  • Source: ProQuest One Psychology
    Journals@Ovid Open Access Journal Collection Rolling
    Hyper Article en Ligne (HAL) (Open Access)
    PubMed Central
    ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait